SCI Foundation is now Unlimit Health. Learn more about what the change means for our ongoing efforts to eliminate neglected tropical diseases

Call to tender: FIDUCIARY AGENT TO ACT AS FISCAL HOST FOR THE FINANCIAL MANAGEMENT OF PROGRAMME GRANTS TO SUPPORT THE MADAGASCAR MINISTRY OF HEALTH

We are inviting all qualified and competent organisations in Madagascar to submit proposals to act as a fiduciary agent that handles all incoming and outgoing programme funds on behalf of the Madagascar Ministry of Health, in line with the Unlimit Health financial guidelines and processes.

Full Story

Malawi becomes the first country to incorporate genital schistosomiasis into national guidelines

In late January, the UK Parliament's International Development Committee released their report on UK aid impact on sexual and reproductive health. One of the report’s key recommendations was for the integration of and care for people affected by female genital schistosomiasis – a little known but painful and debilitating disease affecting millions of women - into broader sexual and reproductive health (SRH) programming.

Full Story

Winner of Unlimit Health’s poster competition reflects on her experience at the Houses of Parliament

To mark World Neglected Tropical Diseases (NTDs) Day on 30th January 2024, Unlimit Health held the Shine a Light poster competition for a second year. The competition aims to raise awareness of NTDs among children and young people. The winners were invited to an event at the Houses of Parliament where they had the opportunity to listen to speeches by people affected, and meet organisations working to eliminate these diseases.

Full Story

Event in parliament calls for continued collaboration and investment in neglected tropical diseases

The All-party Parliamentary Group (APPG) on Malaria and Neglected Tropical Diseases (NTDs) and the UK Coalition Against NTDs organised an event at the House of Lords under the theme ‘Unite, Act, Eliminate’ to commemorate World NTD Day on 30 January.

Full Story

Children across the UK shine a light on neglected tropical diseases

Today, on World Neglected Tropical Diseases Day, Unlimit Health is delighted to announce the winners of this years’ Shine a Light poster competition.

Full Story

Unlimit Health continues commitment to supporting paediatric treatment against schistosomiasis

Following the recent European Medicines Agency (EMA) positive scientific opinion for arpraziquantel to treat schistosomiasis in preschool-aged children, Unlimit Health reaffirms its commitment to supporting paediatric treatment against this parasitic infection.

Full Story

European Medicines Agency recommends Arpraziquantel for treatment of schistosomiasis in preschool-aged children

Today, the Pediatric Praziquantel Consortium announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive scientific opinion for arpraziquantel to treat the neglected tropical disease, schistosomiasis, in preschool-aged children (3 months to 6 years of age).

Full Story

Funding the needs not the NTD label – what will it take?

The neglected tropical diseases (NTDs) funding landscape is evolving rapidly, requiring a radically different funding architecture, as well as additional investment, to effectively impact universal health coverage and reach the last mile in efforts to end parasitic diseases.

Full Story

Unlimit Health announces the appointment of its CEO as co-President elect at the Royal Society of Tropical Medicine and Hygiene

Unlimit Health is delighted by the appointment of its CEO Dr Wendy Harrison as co-President elect of the Royal Society of Tropical Medicine and Hygiene (RSTMH) alongside Professor Margaret Gyapong.

Full Story

Unlimit Health logo

Please help end parasitic disease

Sign up for our mailing list to stay updated with important news, inspiring stories, the latest research, and opportunities to support our vital work.

This field is for validation purposes and should be left unchanged.
Name

We’ll never distribute your email address to any third party. You may opt out at any time. View our privacy policy.